Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • 1995-1999  (2)
  • CD86  (2)
  • CD80  (1)
  • 1
    Electronic Resource
    Electronic Resource
    Springer
    Archives of dermatological research 291 (1999), S. 548-554 
    ISSN: 1432-069X
    Keywords: Key words Langerhans cells ; Co-stimulatory ¶molecules ; CD86 ; TNFα
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract By their potent antigen-presenting function, dendritic cells (DCs) play a crucial role in the initiation of T cell-mediated immunity, including allergic contact hypersensitivity. To acquire such potent antigen-presenting ability, DCs in tissue must be activated, with increased expression of costimulatory molecules. Recent progress in DC biology has demonstrated that DCs can be activated via a variety of substances, e.g. various cytokines, CD40 ligand, bacterial products, and haptens, to increase their antigen-presenting ability, probably by different mechanisms. Therefore, in this study, to elucidate the mechanisms underlying the efficacy of the immunosuppressive drugs dexamethasone (DEX), cyclosporine A (CY), and vitamin D3 (Vit D3) in the modulation of allergic contact hypersensitivity reactions, we examined the effects of these drugs on CD86 and HLA-DR antigen expression and TNFα secretion by monocyte-derived DCs stimulated with two representative haptens, NiCl2 and DNCB, in vitro. The augmented expression of CD86 induced by NiCl2 and DNCB was significantly suppressed by DEX at concentrations in the range 10–8 to 10–5 M, which include concentrations less than its therapeutically effective concentration of 10–7 M. Vit D3 also significantly suppressed NiCl2- and DNCB-induced augmented expression of CD86, at concentrations in the ranges 10–9 to 10–7 M and 10–10 to 10–7 M, respectively. In contrast, significant suppressive effects of CY on the NiCl2- or DNCB-induced augmented expression of CD86 were seen only at concentrations in the range 10–6 to 10–5 M, which are more than ten times higher than its effective concentration for T cell suppression. The augmented expression of HLA-DR antigen, which was only induced by stimulation with NiCl2, was resistant to treatment with these three drugs. Only DEX suppressed HLA-DR antigen expression at 10–5 M. TNFα secretion by stimulated DCs was suppressed by DEX and Vit D3, although their effects were not statistically significant. Thus DEX and Vit D3 could modulate allergic contact dermatitis by their clearly demonstrated suppressive effects on the activation of DCs by haptens.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    ISSN: 1432-069X
    Keywords: Key words Atopic dermatitis ; CD40 ; CD54 ; CD80 ; CD86
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract A number of studies have demonstrated an increased frequency of allergen-specific T cells producing increased amounts of interleukin-4 (IL-4) and IL-5, but little interferon-γ in both the peripheral blood and skin lesions of patients with atopic dermatitis (AD). In this study, to further clarify the characteristics of T cells obtained from AD patients, we examined the dependency of the antigen-specific proliferation of peripheral blood mononuclear cells (PBMC) from AD patients on costimulatory molecules. The antigens used were Candida albicans and Dermatophagoides farinae, for which AD patients show increased levels of IgE antibodies. PBMC from control healthy donors stimulated with these antigens incorporated [3H]-thymidine much more than PBMC from AD patients. The addition of anti-CD54, -CD40, -CD80 and -CD86 monoclonal antibodies to the cultures showed that the PBMC required only CD54 and CD86 for stimulation with C. albicans, but required CD54, CD80 and CD86 for stimulation with D. farinae. Among these monoclonal antibodies, the anti-CD54 antibody suppressed the proliferative responses of most PBMC, most effectively followed by the anti-CD86 antibody. However, there were no significant differences in the requirement for costimulatory molecules of PBMC proliferation stimulated with C. albicans or D. farinae between AD patients and healthy donors. Since many studies have suggested that T-helper type 1 and T-helper type 2 immune responses are different in their dependency on CD80 or CD86 costimulation, our present results suggest that the allergen-specific T cells of AD patients are not completely shifted to a T-helper type 2 subset.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...